SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-003598
Filing Date
2021-03-29
Accepted
2021-03-29 11:07:38
Documents
15
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 20-F tmb-20201231x20f.htm 20-F 1356722
2 EX-2.3 tmb-20201231xex2d3.htm EX-2.3 101594
3 EX-4.5 tmb-20201231xex4d5.htm EX-4.5 1236876
4 EX-4.14 tmb-20201231xex4d14.htm EX-4.14 989597
5 EX-8.1 tmb-20201231xex8d1.htm EX-8.1 4318
6 EX-12.1 tmb-20201231xex12d1.htm EX-12.1 9906
7 EX-12.2 tmb-20201231xex12d2.htm EX-12.2 9831
8 EX-13.1 tmb-20201231xex13d1.htm EX-13.1 6350
9 EX-13.2 tmb-20201231xex13d2.htm EX-13.2 6427
10 EX-15.1 tmb-20201231xex15d1.htm EX-15.1 3217
11 GRAPHIC tmb-20201231xex15d1002.jpg GRAPHIC 3206
12 GRAPHIC tmb-20201231x20f003.jpg GRAPHIC 74359
13 GRAPHIC tmb-20201231x20f001.jpg GRAPHIC 45509
14 GRAPHIC tmb-20201231x20f005.jpg GRAPHIC 49658
15 GRAPHIC tmb-20201231x20f002.jpg GRAPHIC 68216
  Complete submission text file 0001558370-21-003598.txt   4058255
Mailing Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
Business Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
GENMAB A/S (Filer) CIK: 0001434265 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 001-38976 | Film No.: 21780041
SIC: 2834 Pharmaceutical Preparations